BIO India Conference presenters are announced.
Share:
Press Release Summary:
BIO announced initial companies selected through competitive screening process to present at inaugural BIO India International Partnering Conference, which will be held Sept 21-22 in Hyderabad, India. Companies include Aurigene Discovery Technologies; Cellworks; Connexios Life Sciences; CureVac GmbH; Incozen Therapeutics Pvt, Ltd; Indus Biotech Pvt, Ltd; Jubilant BioSys Ltd; KemWell Pharma; Mitra Biotech Pvt, Ltd; Novalead Pharma Pvt, Ltd; Novo Nordisk A/S; and Spectrum Pharmaceuticals.
Original Press Release:
BIO Announces Initial Companies Selected to Present at the Inaugural BIO India International Partnering Conference
Conference will be held September 21-22 in Hyderabad, India
WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) today announced initial companies selected through a competitive screening process to present at the inaugural BIO India International Partnering Conference.
"Our distinguished Advisory Committee recommended these companies because they represent significant investment opportunities based on their promising innovative therapeutic advances," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO. "These firms are a snapshot representing the growth of R&D as well as pure discovery work in India. We look forward to announcing additional companies shortly."
The following companies will present at Bio India:
Aurigene Discovery Technologies
Cellworks
Connexios Life Sciences
CureVac GmbH
Incozen Therapeutics Pvt, Ltd.
Indus Biotech Pvt, Ltd.
Jubilant BioSys Ltd.
KemWell Pharma
Mitra Biotech Pvt, Ltd.
Novalead Pharma Pvt, Ltd.
Novo Nordisk A/S
Spectrum Pharmaceuticals
A total of 30 presenting companies will be selected and posted on the conference website on a rolling basis. To view the latest list of presenting companies, please visit www.bio.org/bioindia.
Presenting companies were nominated by the BIO India Advisory Committee:
Dr. Rashmi Barbhaiya, CEO and Managing Director, Advinus Therapeutics Pvt, Ltd.
Dr. Simon Best, CEO, Aquapharm, Ltd. and Chairman, Edinburgh BioQuarter
Dr. Vijay Chandru, Chairman and CEO, Strand LS & President, ABLE
Mr. Jim Geraghty, Senior Vice President, Genzyme, Inc.
Mr. William Greene, Managing Director, MPM Capital
Mr. Joel Marcus, CEO, Alexandria Real Estate Equities, Inc.
Mr. Sri Mosur, President and CEO, Jubilant Discovery Services, Inc. and Jubilant Biosys, Ltd.
Mr. Utkarsh Palnitkar, Executive Director, Centrum Capital, Ltd.
Dr. Jasmin Patel, Managing Director, FIL Capital Advisors (India) Pvt Ltd.
Dr. Swati Piramal, Vice Chairperson, Piramal Lifesciences, Ltd.
Dr. Sunny Sharma, Managing Director, Asia, OrbiMed Advisors India Private, Ltd.
Mrs. Kiran Mazumdar Shaw, Chairman & Managing Director, Biocon, Ltd.
Mr. Sujay J. Shetty, Leader, Pharma Life Sciences Advisory, PricewaterhouseCoopers (PwC)
Mr. K.V. Subramaniam, President & CEO, Reliance Life Sciences
Dr. M. Vidyasagar, Cecil and Ida Green (II) Chair Professor, Erik Jonsson School of Engineering & Computer Science, The University of Texas at Dallas
BIO India will bring together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India's emerging biotech sector.
BIO brings to India more than ten years of experience and expertise in biotech and pharmaceutical partnering. BIO is renowned for its successful partnering meetings in the U.S., Japan and Germany, including the biotech world's largest partnering event, the Business Forum, at the BIO International Convention. ABLE, BIO's partner in India, brings to the meeting extensive local expertise and its comprehensive network of Indian and Asian biotech and pharmaceutical companies.
Private one-on-one meetings between investors, large biotech and pharmaceutical companies and emerging Indian biotech companies will be arranged through BIO's new state-of-the-art software.
To learn more about BIO India, including registration and program information, please visit www.bio.org/bioindia. Registration is complimentary for qualified investors and credentialed members of the media.
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
About ABLE
ABLE is a national forum that represents the India biotechnology sector. ABLE was launched by leaders in the biotech industry and has over 200 members from various verticals in the biotech sector. ABLE's objectives are to promote entrepreneurship, investments and partnerships in the biotech sector, working with the government in their biotech initiatives and disseminating information on the biotech sector.
